Annual Lung SPORE Workshop (Abstract Submission)
75 submissions
Created | First Name | Last Name | Phone | Select a Session Topic | Abstract Title | First Author First Name | First Author Last Name | Affiliation | List of Additional Authors | Your Abstract Submission | Upload Abstract | Special Characters Included? | Abstract Review Status | Upload Poster | Poster Uploaded | Operations | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mon, 03/11/2024 - 10:17 | Kersten | Pierre | kpier26@emory.edu | 8324019591 | Session 2: Health Disparities in Lung Cancer, Session 3: Immuno-oncology | Communication Issues in Patient/Provider Discussions of Immunotherapy | Kersten | Pierre | Winship Cancer Institute at Emory University |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 09:40 | Francisco | Exposito | francisco.exposito@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Investigating Lkb1 loss as novel synthetic vulnerability in EGFR-driven lung cancer | Francisco | Exposito | Yale Cancer Center, New Haven; Yale School of Medicine, New Haven, USA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | |||||
Mon, 03/11/2024 - 09:20 | Andrey | Ivanov | andrey.ivanov@emory.edu | (404) 727-6343 | Session 6: Cancer Biology | The AVERON Notebook: a computational approach to druggable cancer dependencies enabled by mutant-directed protein-protein interactions. | Hongyue (Nicole) | Chen | Emory University |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
Mon, 03/11/2024 - 09:03 | Rebecca | Starble | rebecca.starble@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Epigenetic priming promotes acquisition of tyrosine kinase inhibitor resistance and oncogene amplification in human lung cancer | Rebecca | Starble | Yale University |
|
Abstract_Submission.pdf |
Starble_Yale_Session1.docx12.64 KB
|
No | Approved to be a Speaker | ||||
Mon, 03/11/2024 - 08:39 | Jordan | Cardenas | jordan.cardenas@yale.edu | 3039196514 | Session 3: Immuno-oncology | The combination of modified IL-18 with anti-PD1 elicits a CD4+ T cell-mediated antitumor response in MHC Class I-deficient models of non-small cell lung cancer | Jordan | Cardenas | Yale |
|
Abstract_Submission.pdf |
Cardenas_Yale_Session 3.docx14.99 KB
|
No | Approved to be a Poster Presenter |
![]() |
||
Mon, 03/11/2024 - 06:48 | Elliott | Brea | elliott_brea@dfci.harvard.edu | 8479221042 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Development and effectiveness of TROP2 CAR T in EGFRm NSCLC including in TROP2 ADC refractory settings | Elliott | Brea | DFCI |
|
Abstract_Submission.pdf |
Brea_DFCI_1.docx17.97 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 03:50 | James | Kim | James.Kim@UTSouthwestern.edu | 214-648-4180 | Session 4: Small Cell Lung Cancer | A Model of Human Small Cell Lung Cancer Metastasis Utilizing Orthotopic Transplantation of Patient-Derived Xenografts | Shreoshi | Pal Choudhuri | University of Texas Southwestern |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 00:35 | Jianfeng | Li | jianfeng.li@emory.edu | (412) 973-4647 | Session 3: Immuno-oncology | Uncovering the rewired IAP-JAK regulatory axis as an immune-dependent vulnerability of LKB1-mutant lung cancer | Changfa | Shu | Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
Mon, 03/11/2024 - 00:05 | Kevin | Levine | klevine2@fredhutch.org | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Continued EGFR Dependency in a Patient with Lung Cancer Harboring an EGFR Kinase Domain Duplication | Kevin | Levine | Fred Hutch Cancer Center |
|
Abstract_Submission.pdf |
Levine_FredHutch_Session1.docx19.63 KB
|
No | Approved to be a Poster Presenter |
![]() |
|||
Sun, 03/10/2024 - 23:49 | Ling | Cai | ling.cai.30@gmail.com | 2146975362 | Session 6: Cancer Biology | A Lung Cancer Mouse Model Database | Ling | Cai | Quantitative Biomedical Research Center, School of Public Health, University of Texas Southwestern Medical Center | Abstract_Submission.pdf |
Cai_UTSW_6.docx15.39 KB
|
No | Approved to be a Poster Presenter |
![]() |
|||
Sun, 03/10/2024 - 21:37 | Tang | Tang | tang.tang@yale.edu | 5307509166 | Session 3: Immuno-oncology | Modeling immune evasion and immunotherapy response in distant metastases of lung adenocarcinoma | Tang | Tang | Yale School of Medicine |
|
Abstract_Submission.pdf |
Tang_Yale_Session 3.docx18.49 KB
|
No | Approved to be a Poster Presenter | |||
Sun, 03/10/2024 - 20:59 | Stefan | Harry | sharry@mgh.harvard.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Systematic Targeting of Protein Complexes with Staples | Stefan | Harry | Harvard University and MGH |
|
Abstract_Submission.pdf |
abstract.docx13.34 KB
|
No | Approved to be a Speaker | ||||
Sun, 03/10/2024 - 20:52 | Matthew | Wang | matthew.wang.mcw69@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Understanding the role of alternative RNA splicing in Osimertinib resistance in lung adenocarcinoma | Matthew | Wang | Department of Molecular Biophysics and Biochemistry, Yale University, USA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter |
![]() |
||||
Sun, 03/10/2024 - 20:25 | Diane | Yang | dyang17@mgh.harvard.edu | Session 6: Cancer Biology | Profiling the protein interactome through cysteine-reactive libraries has revealed the identification of EML4ALK dimerizers | Diane | Yang | Department of Pathology, Massachusetts General Hospital, Boston, MA |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | |||||
Sun, 03/10/2024 - 20:25 | Alice | Berger | ahberger@fredhutch.org | 2066676281 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Systematic discovery of osimertinib resistance variants using CRISPR prime editing | Alice | Berger | Fred Hutch | Abstract_Submission.pdf | No | Approved to be a Speaker | |||||
Sun, 03/10/2024 - 20:03 | Caro | Kravitz | caro.kravitz@yale.edu | Session 6: Cancer Biology | The lysine demethylase KDM2A regulates tumor cell clustering to potentiate metastasis | Caro | Kravitz | Yale University |
|
Abstract_Submission.pdf |
Kravitz_Yale_Session_6.docx16.55 KB
|
No | Approved to be a Poster Presenter | ||||
Sun, 03/10/2024 - 17:40 | Jia | Luo | jia_luo@dfci.harvard.edu | 6176323000 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Clinicopathologic and genomic features of patients with mucinous lung adenocarcinoma and response to systemic therapies | Alessandro | Di Federico | DFCI |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
Sun, 03/10/2024 - 16:59 | Triparna | Sen | triparna.sen@mssm.edu | 9179723836 | Session 3: Immuno-oncology | ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes anti-tumor immunity in SCLC. | Triparna | Sen | Icahn School of Medicine at Mount Sinai | Abstract_Submission.pdf |
Sen_Mount Sinai_Session 3.docx19.04 KB
|
No | Approved to be a Poster Presenter | ||||
Sun, 03/10/2024 - 16:56 | Siyuan | Wang | siyuan.wang@yale.edu | 2037854511 | Session 6: Cancer Biology | A genome-wide single-cell 3D genome atlas of lung cancer progression | Miao | Liu | Yale University Department of Genetics |
|
Abstract_Submission.pdf |
Wang_Yale_Session6.docx13.78 KB
|
No | Approved to be a Poster Presenter | |||
Sun, 03/10/2024 - 16:02 | Triparna | Sen | triparna.sen@mssm.edu | 9179723836 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Multi-omic characterization of KRAS/STK11/KEAP1 co-mutant non-small cell lung cancer (NSCLC) displays a unique metabolic profile and therapeutic vulnerabilities. | Triparna | Sen | Icahn School of Medicine at Mount Sinai | Abstract_Submission.pdf |
Sen_Mount Sinai_Session 1.docx20.44 KB
|
No | Approved to be a Speaker |